KMYY(SH:600518)2024-10-30 11:37Financial Performance - The company's operating revenue for Q3 2024 reached ¥1,399,219,327.56, representing a year-on-year increase of 20.92%[2] - The net profit attributable to shareholders of the listed company was -¥10,744,788.24, with a year-to-date net profit of ¥5,015,537.60[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥71,387,593.90 for the quarter, with a year-to-date figure of -¥179,522,209.77[2] - Total operating revenue for the first three quarters of 2024 reached RMB 3,873,558,308.67, an increase of 9.6% compared to RMB 3,534,121,140.35 in the same period of 2023[19] - Net profit for the first three quarters of 2024 was RMB 8,110,876.11, a significant recovery from a net loss of RMB 146,538,808.79 in the same period of 2023[20] - The total comprehensive income for the first three quarters of 2024 was RMB 7,992,736.50, compared to a loss of RMB 146,552,210.84 in the same period of 2023[20] - The basic earnings per share for the first three quarters of 2024 was RMB 0.000, recovering from a loss of RMB -0.011 in the same period of 2023[20] - The company reported a significant increase in other income, totaling CNY 56,276,630.85 in the first three quarters of 2024, compared to CNY 12,030,755.76 in the same period of 2023[25] - The company reported a total comprehensive loss of CNY -62,711,026.80 for the first three quarters of 2024, compared to a loss of CNY -188,440,216.73 in the same period of 2023[26] Assets and Liabilities - The total assets at the end of the reporting period were ¥14,193,606,641.81, a decrease of 0.61% compared to the end of the previous year[4] - The equity attributable to shareholders of the listed company was ¥7,041,867,572.61, showing a slight decrease of 0.08% from the previous year[4] - As of September 30, 2024, current assets totaled approximately CNY 7.01 billion, an increase of 2.94% from CNY 6.81 billion at the end of 2023[16] - Total liabilities decreased to approximately CNY 7.12 billion, down 1.1% from CNY 7.20 billion at the end of 2023[18] - The company's total assets amounted to approximately CNY 14.19 billion, down from CNY 14.28 billion at the end of 2023[18] - The company's equity attributable to shareholders decreased slightly to approximately CNY 7.04 billion from CNY 7.05 billion at the end of 2023[18] - Total liabilities increased to CNY 5,331,453,002.06 from CNY 5,198,102,225.72, reflecting a rise of about 2.6%[24] - The total equity decreased to CNY 11,773,635,746.80 from CNY 11,847,062,846.60, reflecting a decline of approximately 0.6%[24] Cash Flow - The company reported a net cash flow from operating activities of -¥349,692,169.54 year-to-date, indicating ongoing cash flow challenges[2] - The company reported a net cash outflow from operating activities of RMB -349,692,169.54, compared to RMB -253,310,510.35 in the first three quarters of 2023[21] - The net cash inflow from investment activities was CNY 25,799,187.84, compared to a net outflow of CNY 5,497,108.54 in the previous year[22] - The net cash outflow from financing activities was CNY -36,046,035.02, compared to CNY -81,977,348.86 in the previous year, indicating an improvement[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 233,318, with the largest shareholder holding 3,509,413,788 shares, representing 25.31%[9] - The second-largest shareholder, China Construction Bank Guangdong Branch, holds 653,206,909 shares, accounting for 4.71%[9] - The company’s major shareholders have not participated in any securities lending or borrowing activities during the reporting period[11] Bankruptcy and Legal Matters - The company’s wholly-owned subsidiary, Kangmei Traditional Chinese Medicine City (Puning) Co., Ltd., has been applied for bankruptcy liquidation due to inability to repay debts[12] - The company has completed compensation of 2,458.93 million RMB to 52,037 investors as part of its bankruptcy reorganization plan[14] - The company is actively pursuing legal claims against other responsible parties for a total of 2,607.73 million RMB in compensation[15] - The company is monitoring the ongoing litigation regarding the bankruptcy of its subsidiary and will fulfill its disclosure obligations as required by law[12] - The company has received a court ruling regarding the execution of real estate related to a financial loan dispute, which has been withdrawn[15] - The company is committed to maintaining normal operations at its subsidiary while addressing the bankruptcy claims[12] - The company will continue to communicate with creditors to mitigate negative impacts and protect shareholder interests[12] Operational Metrics - The company reported a significant increase of 61.28% in accounts receivable financing, attributed to an increase in accepted bills compared to the previous year[7] - The company experienced a 53.59% increase in other non-current assets, mainly due to an increase in prepaid equipment[7] - The company recorded a 91.09% increase in investment income, primarily due to gains from debt restructuring during the period[7] - Research and development expenses decreased to RMB 32,164,804.25, down 15.1% from RMB 37,842,182.24 in the previous year[19] - Sales expenses were reduced to RMB 312,989,742.49, a decrease of 28.5% compared to RMB 437,359,803.22 in the same period of 2023[19] - Accounts receivable rose to approximately CNY 2.26 billion, reflecting an increase of 11.1% from CNY 2.03 billion at the end of 2023[16] - Inventory increased to approximately CNY 2.89 billion, up 9.1% from CNY 2.64 billion at the end of 2023[16]